Pay in 4 interest-free payments of $6.05 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
SURMOUNT-5 Cost-Effectiveness Model Design A patient-level simulation model was developed to compare tirzepatide and semaglutide using data from the SURMOUNT-5 Phase 3 clinical trial
For weight management (Wegovy), the titration continues through 1.7 mg to a maintenance dose of 2.4 mg weekly
Pricing varies and its clinical design is gender-neutral rather than female-specific, which means women with hormonal factors or PCOS-related weight management challenges may find the approach less tailored than theyd like
Wagner, T
Compounded tirzepatide from 503A pharmacies provides customized dosing at more affordable prices than brand-name versions
Long-Term Safety Data Semaglutide has been studied in both short-term and long-term clinical trials
US$ 20.64
US$ 25.34
US$ 27.20
US$ 20.15
US$ 20.70
US$ 25.63
